Extendicare (EXE) Stock Price, News & Analysis

Company Overview

Extendicare Inc., operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Key Stats

• Today's Range: C$14.79 to C$14.95
• 50-Day Range: C$12.27 to C$15.22
• 52-Week Range: C$8.96 to C$15.32
• Volume: 23,416 shs
• Average Volume: 182,627 shs
• Market Capitalization: C$1.24 billion
• P/E Ratio: 15.35
• Dividend Yield: 3.30%
• Price Target: C$15.20
• Consensus Rating: Moderate Buy

Extendicare Stock Analysis - MarketRank™

Extendicare scored higher than 38% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Extendicare has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Extendicare is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Extendicare has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Extendicare is 15.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.72.

Price to Earnings Ratio vs. Sector

The P/E ratio of Extendicare is 15.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 86.16.

Price to Book Value per Share Ratio

Extendicare has a P/B Ratio of 10.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for EXE.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Extendicare pays a meaningful dividend of 3.40%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Extendicare does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Extendicare is 50.57%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for EXE.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.61

News Sentiment

Extendicare has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Extendicare this week, compared to 1 article on an average week.

Search Interest

30 people have searched for EXE on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Extendicare insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 17.67% of the stock of Extendicare is held by institutions.

EXE Stock Analysis - Frequently Asked Questions

How have EXE shares performed this year?

Extendicare's stock was trading at C$10.63 at the beginning of the year. Since then, EXE stock has increased by 39.8% and is now trading at C$14.86.

How were Extendicare's earnings last quarter?

Extendicare Inc. (TSE:EXE) released its quarterly earnings data on Tuesday, November, 12th. The company reported $0.19 EPS for the quarter. Extendicare had a net margin of 4.48% and a trailing twelve-month return on equity of 64.13%.
Read the conference call transcript.

How do I buy shares of Extendicare?

Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Extendicare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Extendicare investors own include Enbridge (ENB), Enterprise Products Partners (EPD), Algonquin Power & Utilities (AQN), Bank of Nova Scotia (BNS), NVIDIA (NVDA), Pembina Pipeline (PPL) and BCE (BCE).

Company Calendar

• Last Earnings: 11/12/2024
• Record date for 8/15 Dividend: 7/31/2025
• Ex-Dividend for 8/15 Dividend: 7/31/2025
• Dividend Payable: 8/15/2025
• Ex-Dividend for 9/15 Dividend: 8/29/2025
• Record date for 9/15 Dividend: 9/15/2025
• Dividend Payable: 9/15/2025
• Today: 10/09/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: TSE:EXE
• CIK: N/A
• Web: www.extendicare.com
• Phone: 905-470-4000
• Fax: N/A
• Employees: 23,000
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Extendicare: C$15.20
• High Price Target: C$18.00
• Low Price Target: C$11.00
• Potential Upside/Downside: +2.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): C$0.97
• Trailing P/E Ratio: 15.39
• Forward P/E Ratio: 24.21
• P/E Growth: N/A
• Net Income: C$65.46 million
• Net Margins: 4.48%
• Pretax Margin: N/A
• Return on Equity: 64.13%
• Return on Assets: 7.16%

Debt

• Debt-to-Equity Ratio: 283.02
• Current Ratio: 0.62
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: C$1.51 billion
• Price / Sales: 0.83
• Cash Flow: C$4.64 per share
• Price / Cash Flow: 3.20
• Book Value: C$1.40 per share
• Price / Book: 10.64

Miscellaneous

• Outstanding Shares: 83,818,000
• Free Float: N/A
• Market Cap: C$1.24 billion
• Optionable: Not Optionable
• Beta: 0.88